Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.415
+0.135 (10.55%)
At close: Jun 26, 2026, 4:00 PM EDT
1.420
+0.005 (0.33%)
After-hours: Jun 26, 2026, 7:32 PM EDT
Enveric Biosciences Employees
As of December 31, 2025, Enveric Biosciences had 6 total employees, including 5 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
6
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,929,997
Market Cap
5.21M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 39 |
| PMGC Holdings | 34 |
| GeoVax Labs | 19 |
| FibroBiologics | 15 |
| Processa Pharmaceuticals | 12 |
| TransCode Therapeutics | 12 |
| Dermata Therapeutics | 9 |
| Alzamend Neuro | 6 |
ENVB News
- 11 days ago - Enveric Biosciences Announces Participation in 2026 BIO International Convention - Business Wire
- 18 days ago - Enveric Biosciences to Participate in the UBS 3rd Virtual CNS Day - Business Wire
- 25 days ago - Enveric Biosciences initiates IND-enabling Genotoxicity studies of EB-003 - TheFly
- 25 days ago - Enveric Biosciences Initiates Investigational New Drug (IND)-enabling Genotoxicity Studies of Lead Neuroplastogen Candidate EB-003 - Business Wire
- 5 weeks ago - Enveric Biosciences reports preclinical results from analysis of EB-003 - TheFly
- 5 weeks ago - Enveric Biosciences Reports Positive Preclinical Results from Phototoxicity Analysis for Lead Neuroplastogen Candidate EB-003 - Business Wire
- 6 weeks ago - Enveric Biosciences reports Q1 EPS ($1.08) vs. ($14.58) last year - TheFly
- 6 weeks ago - Enveric Biosciences sees cash runway into 1Q27 - TheFly